We analyze and invest in new medicines

Vibe Bio invests in biotechs developing high-potential therapeutics from pre-seed through Series A. Our proprietary AI helps us evaluate programs and make data-driven investments.

We back founder-led biotechs

Vibe Bio invests in therapeutics companies across modalities and indications. We have a particular interest in platform technologies and rare or overlooked diseases.

Analyze drug programs with AI

VibeOne is our software platform that supports strategic decisions in biopharma. AI enables leadership teams to generate TPP benchmarks, perform PTRS & risk assessments, track competitive intelligence, prioritize portfolio programs, and produce financial valuations.


VibeCast is our informational podcast and content series exploring the hottest topics in drug development.

Guests include biotech founders, regulatory experts, drug development executives, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.